These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 621843)

  • 21. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
    Domínguez Ortega L
    Rev Clin Esp; 1992 Jul; 191(3):169. PubMed ID: 1502409
    [No Abstract]   [Full Text] [Related]  

  • 22. [Iatrogenic Cushing's syndrome caused by dexamethasome suppositories].
    Vilaseca J; Tor J; Libenson C; Guardia J
    Rev Clin Esp; 1980 Dec; 159(6):437-8. PubMed ID: 7221114
    [No Abstract]   [Full Text] [Related]  

  • 23. [Warning for Cushing's syndrome and withdrawal symptoms in users of the Hong Kong pill].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1978 Oct; 122(42):1633. PubMed ID: 309100
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of 2 topical steroids preparations: desoximetasone and betamethasone dipropionate].
    Magnin PH; Torchinsky O; Baabour SD
    Med Cutan Ibero Lat Am; 1978; 6(3-4):203-8. PubMed ID: 398919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
    Estruch R; Tassies D; Beltrán J; Halperin EI
    Rev Clin Esp; 1991 Nov; 189(7):344-5. PubMed ID: 1767094
    [No Abstract]   [Full Text] [Related]  

  • 26. Cushing's syndrome caused by analgesic/dexamethasone preparation.
    Chan TY; Tsoi WW
    Ann Pharmacother; 1994 Dec; 28(12):1411. PubMed ID: 7696736
    [No Abstract]   [Full Text] [Related]  

  • 27. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
    Willis I; Cornell RC; Penneys NS; Zaias N
    Clin Ther; 1986; 8(3):275-82. PubMed ID: 3521856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of desoximetasone and hydrocortisone butyrate in psoriasis.
    Zachariae H
    Acta Derm Venereol; 1976; 56(4):309-10. PubMed ID: 60029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cushing's syndrome secondary to inhaled corticosteroids mimicking HIV-associated lipodystrophy.
    le Roux CW; Beckles MA; Besser GM; Pinching AJ; Davison AG
    HIV Med; 2001 Apr; 2(2):133-5. PubMed ID: 11737390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cushing's syndrome caused by short-term topical glucocorticoid use for erythrodermic psoriasis and development of adrenal insufficiency after glucocorticoid withdrawal.
    Durmazlar SP; Oktay B; Eren C; Eskioglu F
    Eur J Dermatol; 2009; 19(2):169-70. PubMed ID: 19106046
    [No Abstract]   [Full Text] [Related]  

  • 31. Cushing's syndrome due to an adrenal adenoma with paradoxical response to dexamethasone.
    Meinders AE; De Vries F
    Neth J Med; 1983; 26(3):84-7. PubMed ID: 6843742
    [No Abstract]   [Full Text] [Related]  

  • 32. Outbreak of exogenous Cushing's syndrome due to unlicensed medications.
    Azizi F; Jahed A; Hedayati M; Lankarani M; Bejestani HS; Esfahanian F; Beyraghi N; Noroozi A; Kobarfard F
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):921-5. PubMed ID: 18462262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The diagnosis of Cushing's syndrome. Results of diagnostic assessment of 20 patients with Cushing's syndrome of variable etiology (1979-1989)].
    Caduff F; Staub JJ; Nordmann A; Radü EW; Landolt H
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):10-20. PubMed ID: 1990418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.
    Tempark T; Phatarakijnirund V; Chatproedprai S; Watcharasindhu S; Supornsilchai V; Wananukul S
    Endocrine; 2010 Dec; 38(3):328-34. PubMed ID: 20972726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cushing's syndrome due to abuse of dexamethasone nasal spray.
    Ortega LD; Grande RG
    Lancet; 1979 Jul; 2(8133):96. PubMed ID: 87988
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease.
    Lamberts SW; Klijn JG; de Jong FH; Birkenhäger JC
    JAMA; 1979 Oct; 242(15):1640-3. PubMed ID: 39183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of dexamethasone suppression test to indicate bilateral adrenocortical hyperplasia in Cushing's syndrome.
    SILVERMAN SR; MARNELL RT; SHOLITON LJ; WERK EE
    J Clin Endocrinol Metab; 1963 Feb; 23():167-72. PubMed ID: 13992947
    [No Abstract]   [Full Text] [Related]  

  • 38. Iatrogenic Cushing's syndrome and adrenal insufficiency in infants on intranasal dexamethasone drops for nasal obstruction - Case series and literature review.
    Joshi RR; Maresh A
    Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():123-126. PubMed ID: 29447799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma testosterone profiles in Cushing's syndrome.
    Smals AG; Kloppenborg PW; Benraad TJ
    J Clin Endocrinol Metab; 1977 Aug; 45(2):240-5. PubMed ID: 195973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cushing's syndrome induced by enhanced systemic absorption of topical corticosteroids when co-administered with hand sanitiser in a patient with COVID-19-induced chronic plaque psoriasis.
    Truong K; Thai KE
    Skin Res Technol; 2023 Jun; 29(6):e13375. PubMed ID: 37357655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.